Showing results (301-310 of 319) with videos related to

Sort By:
Pageof 32
Leukemia|August 30, 2019
Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysisStefan Knop, Monika Engelhardt, Peter Liebisch, et al.
Cancers|April 3, 2021
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMMFriederike Bachmann, Martin Schreder, Monika Engelhardt, et al.
Nature Genetics|June 29, 2023
Single-cell multi-omics of mitochondrial DNA disorders reveals dynamics of purifying selection across human immune cellsCaleb A Lareau, Sonia M Dubois, Frank A Buquicchio, et al.
Blood|January 15, 1996
Improved outcome in adult B-cell acute lymphoblastic leukemiaD Hoelzer, W D Ludwig, E Thiel, et al.
The Lancet. Haematology|May 28, 2021
PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trialStefanie Kreissl, Helen Goergen, Ina Buehnen, et al.
Leukemia|February 10, 2016
Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemiaU Krug, W E Berdel, R P Gale, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2025
Cell type-specific purifying selection of synonymous mitochondrial DNA variationCaleb A Lareau, Patrick Maschmeyer, Yajie Yin, et al.
Nature Communications|May 24, 2020
Discrete populations of isotype-switched memory B lymphocytes are maintained in murine spleen and bone marrowRené Riedel, Richard Addo, Marta Ferreira-Gomes, et al.
Lancet (London, England)|October 25, 2017
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study GroupPeter Borchmann, Helen Goergen, Carsten Kobe, et al.
Lancet (London, England)|June 18, 2016
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma NetworkOlivier Hermine, Eva Hoster, Jan Walewski, et al.
Pageof 32